To meet this requirement, mice with severe combined immunodeficiency (SCID), lacking T and B cells and the WT counterpart (with an intact immune system), were challenged with B16 melanoma cells and treated with p62 plasmid. This evidence concerns the gene SQSTM1 and melanoma.